Opus Genetics, Inc. (IRD): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$6.80M
Year ended 2020-12-31
2019-12-31: -$3.62M2020-12-31: -$6.80M-$6.80M
2019-12-31 Free Cash Flow (USD) 2020-12-31
Period endedFree Cash FlowChange YoYSource filing
2020-12-31-$6.80Mn/m2022-03-24, From 2020-01-01
2019-12-31-$3.62Mn/a2021-03-11, From 2019-01-01